Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,65 CAD | -2,94% | -2,94% | -50,75% |
26/03 | Aptose Biosciences Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023 | CI |
26/03 | Transcript : Aptose Biosciences Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 28/10/13 |
C. Payne
DFI | Director of Finance/CFO | 61 | 27/06/22 |
Chief Tech/Sci/R&D Officer | - | 01/11/19 | |
Rafael Bejar
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/01/20 |
Investor Relations Contact | - | - | |
Marc Wiles
LAW | General Counsel | - | - |
Brooks Ensign
AUD | Comptroller/Controller/Auditor | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 19/09/07 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 13/09/22 |
Mark Vincent
BRD | Director/Board Member | 71 | 19/09/07 |
Director/Board Member | 74 | 15/12/14 | |
William Rice
CEO | Chief Executive Officer | 65 | 28/10/13 |
Warren Whitehead
BRD | Director/Board Member | 71 | 07/04/11 |
Carol Ashe
BRD | Director/Board Member | 66 | 15/08/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 15 717 701 | 12 619 162 ( 80,29 %) | 0 | 80,29 % |
Coordonnées société
Aptose Biosciences, Inc.
251 Consumers Road Suite 1105
M2J 4R3, Toronto
+647 479 9828
http://www.aptose.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-50,75% | 19 M | |
+1,77% | 42,86 Md | |
+47,70% | 41,36 Md | |
+12,24% | 42,74 Md | |
-8,83% | 27,68 Md | |
+7,44% | 25,15 Md | |
-23,01% | 18,63 Md | |
+30,56% | 12,37 Md | |
-1,82% | 11,92 Md | |
+8,35% | 11,21 Md |
- Bourse
- Actions
- Action APS
- Société Aptose Biosciences Inc.